• Company
• Ildong Idience presents 1st interim results for Venadaparib
• by Kim, Jin-Gu Jan 25, 2024 05:50am

• Policy
• Chong Kun Dang cuts price of its Lucen BS by half
• by Lee, Tak-Sun Jan 25, 2024 05:50am

• Company
• Boehringer Ingelheim Korea appoints Ana-Maria Boie as new GM
• by Son, Hyung-Min Jan 25, 2024 05:49am

• Company
• Samsung Biologics tops 1 trillion won in profit
• by Chon, Seung-Hyun Jan 25, 2024 05:49am

• Opinion
• [Reporter’s View] KRPIA's new BOD signifies fresh starts
• by Eo, Yun-Ho Jan 25, 2024 05:49am

• Company
• Sales of Esomezol ·Noltec↑ Nexium↓ in the PPI market
• by Kim, Jin-Gu Jan 25, 2024 05:49am

• InterView
• Patent outlook after Forxiga withdrawal in Korea
• by Kim, Jin-Gu Jan 24, 2024 12:37pm

• Opinion
• [Reporter’s View] Supply disruptions disclosed in real-time
• by Lee, Hye-Kyung Jan 24, 2024 05:46am

• Company
• Potential of AVEO Oncology acquired by LG Chem
• by Jan 24, 2024 05:46am

• Company
• ‘I believe in MSD Korea and the Korean government'
• by Eo, Yun-Ho Jan 24, 2024 05:46am